NCT04241848

Brief Summary

Veterans who suffer strokes often have disturbances in the ability to walk that reduces independence and quality of life. Alterations in gait combined with general decreased activity are associated with reduced muscle strength of the paretic leg. This leads to cardiovascular deconditioning and reduced quality of life. There is a new and novel battery powered device (Keeogo powered orthotic exoskeleton) that uses motors that assist knee movement while walking, sitting down, and standing up. The Keeogo monitors hip movement to assist the knee, making it simple to learn how to use. If successful, this project will show how this device will help improve the ability to walk and provide evidence to support larger clinical trials in a home and community setting to improve mobility, increase muscle mass and strength in the legs, as well as improve general health and quality of life. Lastly, this device could be used to increase motivation and confidence in a person to walk for longer periods of time and distance, providing the ability to walk in places that were previously inaccessible.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable stroke

Timeline
Completed

Started Nov 2020

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 30, 2019

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

November 2, 2020

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2024

Completed
1 year until next milestone

Results Posted

Study results publicly available

June 10, 2025

Completed
Last Updated

June 10, 2025

Status Verified

May 1, 2025

Enrollment Period

3.6 years

First QC Date

December 30, 2019

Results QC Date

April 3, 2025

Last Update Submit

May 22, 2025

Conditions

Keywords

StrokeExoskeleton DeviceWalkingNeurological RehabilitationParesisHemiplegia

Outcome Measures

Primary Outcomes (1)

  • Five Times Sit to Stand Test (5xSTS)

    The 5xSTS is used to determine leg power and an aspect of transfer skill. This test will be used to assess a level of improved function while wearing the device. The test will also be used to assess a level of improved function not while wearing the device.

    Change from Baseline after completing 36 training sessions (approximately three months time)

Secondary Outcomes (8)

  • Energy Expenditure

    Change from Baseline after completing 36 training sessions (approximately 3 months time)

  • The Ratio of Stance Time of Each Limb During Ambulation

    Change from Baseline after completing 36 training sessions (approximately three months time)

  • Six Minute Walk Test (6MWT)

    Change from Baseline after completing 36 training sessions (approximately three months time)

  • Ten Meter Walk Test (10MWT)

    Change from Baseline after completing 36 training sessions (approximately three months time)

  • Timed Up and Go (TUG) Test

    Change from Baseline after completing 36 training sessions (approximately three months time)

  • +3 more secondary outcomes

Study Arms (2)

Powered Orthotic Exoskeleton Training Group

EXPERIMENTAL

Participant in 36 session ambulation training using a powered orthotic exoskeleton.

Device: KeeogoOther: Ambulation training

Control Group

ACTIVE COMPARATOR

Participant in 36 session ambulation training without using a powered orthotic exoskeleton.

Other: Ambulation training

Interventions

KeeogoDEVICE

A new and novel type of robotic-device (Keeogo, B-temia, Inc.) was developed to provide powered assistance at the knee for persons with stroke. This device provides assistance for both knee extension and knee flexion during ambulation, transfers to standing and sitting, in addition to ascending and descending stairs. As this device isn't able to fully control the movement, it requires the ability of the patient to stand and initiate stepping. The approach the Keeogo uses to monitor the desired movement in order to appropriately provide assistance. This promotes intuitive learning for the user, minimizing the amount of instruction and practice needed to effectively ambulate allowing users to independently ambulate within one session. This device does not restrict leg movement, so the user can side-step and walk backwards. However, it does not provide assistance during these movements.

Powered Orthotic Exoskeleton Training Group

Ambulation training will consist of mobility activities affecting daily life including: walking; squatting (or getting in and out of a chair); bending, kneeling or stooping (for picking an item up off of the floor); and ascending and descending stairs. Sessions will be monitored and tailored to the individual, based on their functional ability and to ensure their safety.

Control GroupPowered Orthotic Exoskeleton Training Group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and female between 18 and 89 years old;
  • Hemiplegia or hemiparesis due to stroke (\>6 months);
  • \[Able to walk between 0.15-0.75m/s\]
  • Self-reported limitations to mobility and walking activities due to paretic side knee stiffness and loss of range of motion;
  • Weight under 250lbs
  • Desire to increase daily activity levels; and
  • Able and willing to commit to participation and follow directions and communicate basic needs.

You may not qualify if:

  • Neurological paralysis causing an inability to stand, weight bear or take stepping movements;
  • Fixed contractures resulting in limited range of motion in the hip, knees, or ankles that prevent sitting, standing, walking, and/or squatting activities;
  • Modified Ashworth Scale for spasticity greater than 3 in the lower limbs
  • Able to walk at a normal walking speed (1.4 m/s, 3.2 mph) or better during the Six Minute Walk Test (6MWT)
  • Anthropometric incompatibility with the device
  • Femur length less than 36 cm or greater than 45 cm;
  • Upper thigh circumference less than 55 cm or greater than 75 cm;
  • Lower thigh circumference less than 27 cm or greater than 40 cm;
  • Calf circumference less than 33 cm or greater than 49 cm;
  • Ankle circumference less than 27 cm or greater than 40 cm;
  • Shin length less than 26 cm;
  • Waist circumference less than 71 cm or greater than 107 cm;
  • Any medical complication or co-morbidity as judged by the study physician to be contraindicated for wearing the device or walking (e.g., cardiovascular disorders, pressure ulcers, open wounds, lower limb vascular disorders, or other medical conditions); and
  • Pregnant or planning to become pregnant (Females only).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

James J. Peters VA Medical Center, Bronx, NY

The Bronx, New York, 10468-3904, United States

Location

MeSH Terms

Conditions

StrokeParesisHemiplegia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsParalysis

Limitations and Caveats

We were approved to begin this study during the summer of 2020, which was during the first wave of the COVID-19 pandemic. Due to the lockdown status of our VAMC at that time, no participants were permitted to be enrolled. In late April 2021, most restrictions were lifted at our VAMC, and we were able to begin the process of enrolling the targeted number of participants. The delayed start to study procedures, however, led to a smaller than anticipated number of subjects available for analysis.

Results Point of Contact

Title
Dr. Ann Spungen
Organization
James J. Peters VA Medical Center, Spinal Cord Damage Research Center

Study Officials

  • Ann M Spungen, EdD

    James J. Peters Veterans Affairs Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Ambulation training while using the powered orthotic exoskeleton for 36 sessions
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 30, 2019

First Posted

January 27, 2020

Study Start

November 2, 2020

Primary Completion

May 30, 2024

Study Completion

May 30, 2024

Last Updated

June 10, 2025

Results First Posted

June 10, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Where practicable, sharing should take place under a written agreement prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. However, it is permissible for final datasets in machine-readable format to be submitted to and accessed from PubMed Central (and similar sites) provided that care is taken to ensure that the individuals cannot be re-identified using other publicly available information.

Locations